ID Biomedical's Shot in the Arm
33830
ID Biomedical appears well-positioned for the coming years, but it may be best to stay cautious on the company.
618087
A new polymer gel may offer an alternative to the injections required to manage diseases such as diabetes, Crohn&#39;s disease, ulcerative colitis, bowel cancer and infections.
371895
As flu season neared in late September, the drugmaker at the center of the vaccine shortage radiated confidence. By Tim Boyle, Getty Images.
401023
By Anonymous  In an article e-published on April 5 ahead of print in Gene Therapy, Raty et al.
748060
What do you think of the Medicare drug discount-card program? (Check all that apply.). I&#39;m eligible but I don&#39;t use it. Biopsy results confirm a young Dublin man has contracted the human form of mad cow disease.
210999
India - Painful injections and hard to swallow pills for diabetics could be replaced by a gel designed by two Indian scientists which can be simply popped into the mouth, the researchers said on Tuesday.
706106
By Linda Loyd, The Philadelphia Inquirer  Dec. 7--Auxilium Pharmaceuticals Inc. said it has temporarily suspended a late-stage clinical trial of its injectable drug, AA4500, for Dupuytren's disease, a rare finger joint condition, to investigate a manufacturing issue.
22654
A recent study initiated by drug manufacturing company DeCode Genetics of Reykjavik, has come up with startling results. The report was published in âPloS Medicineâ, the on-line journal.
258450
A device projecting an enhanced image of underlying veins onto skin could avoid botched injection attempts.
113717
MINNEAPOLIS - Finals week may be on its way at Augsburg College, but the most pressing question on many minds was: What was in those syringes that a freelancing nurse jabbed into 38 students last week?
5505
ID Biomedical Corp.   said on Thursday  analysis of a clinical trial of its experimental nasal flu  vaccine showed it helps prevent the illness.
255246
An experimental vaccine can trigger the body to fight a type of leukemia that largely affects adults, and can even send recipients into remission.
17093
ID Biomedical Corp. (IDB.TO: Quote, Profile, Research) (IDBE.O: Quote, Profile, Research) signed a 10-year US distribution deal for its Fluviral drug that could reap
203709
Advanced X-ray technology has helped scientists spot a new target that drug designers might use to attack the dreaded bird flu virus.
693990
Intensive-care doctors monitor patients from miles away. Also: Vioxx might be responsible for more deaths than thought.... New network in southern India gives government a big boost.... and more.
641578
NEW YORK, December 6  - ID Biomedical Corp (IDBE.NAS) announced today that it has signed a ten-year US distribution agreement for its Fluviral treatment, expected to generate $2.5 billion in sales and offset the shortage of flu vaccines
399586
TORONTO (CP) - Officials of the US Food and Drug Administration will inspect the Ste-Foy, Que., flu vaccine production plant of ID Biomedical next week in a bid to approve the company&#39;s surplus vaccine for importation to the United States.